Characterization of the activity of L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl-hydrogen phosphate] potassium salt in hydroxyl radical elimination

被引:0
|
作者
Tomita, T [1 ]
Kashima, M [1 ]
Tsujimoto, Y [1 ]
机构
[1] Nihon Univ, Sch Dent, Dept Endodont, Chiba 2718587, Japan
关键词
ESR; hydroxyl radical; scavenging; L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl-hydrogen phosphate] potassium salt;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The effect of L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-( 4,8,12- trimethyltridecyl)-2H-1-benzopyran-6-yl-hydrogen phosphate] potassium salt (EPC-K-1) on hydroxyl radical(. OH) elimination was studied using electron spin resonance (ESR) and spectrophotometric experiments. The addition of EFC-K-t and . OH scavengers eliminated the . OH generated from Cu2+/H2O2, Fe2+/H2O2 and H2O2/UV-irradiation reaction systems. However, in competitive reactions using different concentrations of a spin-trap agent, the addition of the . OH scavenger altered the IC50 values, whereas the addition of EPC-K-1 and a metal chelater did not change the value in the Cu2+/H2O2 and Fe2+/H2O2 reaction systems. The addition of EPC-K-1 and metal chelater changed the ESR signal for free Cu2+. The spectrophotometric experiments confirmed that the addition of EPC-K-1 and metal chelater altered the absorption spectra due to CuCl2 and FeSO4, whereas the . OH scavenger did nut alter the spectra. Therefore, it was demonstrated that EPC-K-1 has the ability both to scavenge . OH directly and to inhibit the generation of . OH by the chelation of Cu2+ and Fe2+.
引用
收藏
页码:330 / 333
页数:4
相关论文
共 50 条
  • [21] 2-{1-[2,8-Bis(trifluoromethyl)quinolin-4-yl]-3,5,6,7,8,8a-hexahydro-1H-1,3-oxazolo[3,4-a]pyridin-3-yl}phenol
    Goncalves, Raoni S. B.
    Kaiser, Carlos R.
    de Souza, Marcus V. N.
    Wardell, James L.
    Wardell, Solange M. S. V.
    Tiekink, Edward R. T.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O1656 - U422
  • [22] 4-OXOSPIRO[BENZOPYRAN-2,4'-PIPERIDINES] AS CLASS-III ANTIARRHYTHMIC AGENTS - PHARMACOLOGICAL STUDIES ON 3,4-DIHYDRO-1'-[2-(BENZOFURAZAN-5-YL)-ETHYL]-6-METHANESULFONAMIDOSPIRO[(2H)-1-BENZOPYRAN-2,4'-PIPERIDIN]-4-ONE (L-691,121)
    ELLIOTT, JM
    SELNICK, HG
    CLAREMON, DA
    BALDWIN, JJ
    BUHROW, SA
    BUTCHER, JW
    HABECKER, CN
    KING, SW
    LYNCH, JJ
    PHILLIPS, BT
    PONTICELLO, GS
    RADZILOWSKI, EM
    REMY, DC
    STEIN, RB
    WHITE, JI
    YOUNG, MB
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (21) : 3973 - 3976
  • [24] Synthesis and antimicrobial screening of novel 9-{2-[(1H-1,2,3-triazol-4-yl)methoxy]phenyl}-3,3,6,6-tetramethyl-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione derivatives
    A. Kishore Kumar
    V. Sunitha
    B. Shankar
    T. Murali Krishna
    Ch. Abraham Lincoln
    P. Jalapathi
    Russian Journal of General Chemistry, 2017, 87 : 2011 - 2020
  • [25] Synthesis and antimicrobial screening of novel 9-{2-[(1H-1,2,3-triazol-4-yl)methoxy]phenyl}-3,3,6,6-tetramethyl-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione derivatives
    Kumar, A. Kishore
    Sunitha, V.
    Shankar, B.
    Krishna, T. Murali
    Lincoln, Ch. Abraham
    Jalapathi, P.
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2017, 87 (09) : 2011 - 2020
  • [26] CARDIAC ELECTROPHYSIOLOGIC AND ANTIARRHYTHMIC ACTIONS OF 3,4-DIHYDRO-1'-[2-(BENZOFURAZAN-5-YL) ETHYL]-6-METHANESULFONAMIDOSPIRO[(2H)-1-BENZOPYRAN-2,4'-PIPERIDIN]-4-ONE HCL (L-691, 121), A NOVEL CLASS-III AGENT
    LYNCH, JJ
    WALLACE, AA
    VANDERGAAG, LH
    BASKIN, EP
    BEAR, CM
    GEHRET, JR
    KOTHSTEIN, T
    STUPIENSKI, RF
    APPLEBY, SD
    SANGUINETTI, MC
    JURKIEWICZ, NK
    ZINGARO, GJ
    STEIN, RB
    CLAREMON, DA
    ELLIOTT, JM
    YOUNG, MB
    BALDWIN, JJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 265 (02): : 720 - 730
  • [27] 2-(4,5,6,7-Tetrafluorobenzimidazol-2-yl)-4,4,5,5-tetramethyl-4,5-dihydro-1H-imidazole-3-oxide-1-oxyl, A Hydrogen-Bonded Organic Quasi-1D Ferromagnet (vol 130, pg 186, 2008)
    Murata, Hidenori
    Miyazaki, Yuji
    Inaba, Akira
    Paduan-Filho, Armando
    Bindilatti, Valdir
    Oliveira, Nei Fernandes, Jr.
    Delen, Zeynep
    Lahti, Paul M.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2016, 138 (06) : 2062 - 2062
  • [28] Crystal structure of 2-(4,6-dimethyl-12,13-dihydro-6H-6,12-methanobenzo [7,8][1,5]oxazocino[3,4-g]quinolin-2-yl)phenol and its recognition of Sn4+
    Zhou, Ying
    Ye, Xin-ru
    Tan, Xin-xin
    Huang, Wan-ting
    Zhang, De-Hua
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1328
  • [29] Synthesis and Antibacterial Activity of Some Novel 6-(1H-Benz[d]imidazol-2-yl)-8-(5-nitro-2-furyl)-3-(4-pyridyl)-7,8-dihydro[1,2,4]triazolo[3,4-b][1,3,4]thiadiazepines
    Reddy, Vanga Malla
    Reddy, Kunduru Ravinder
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2010, 58 (08) : 1081 - 1084
  • [30] Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines
    Schnekenburger, Michael
    Goffin, Eric
    Lee, Jin-Young
    Jang, Young
    Mazurnder, Aloran
    Ji, Seungwon
    Rogister, Bernard
    Bouider, Nafila
    Lefranc, Florence
    Miklos, Walter
    Mathieu, Veronique
    de Tullio, Pascal
    Kirn, Kyu-Won
    Dicato, Mario
    Berger, Walter
    Han, Byung Woo
    Kiss, Robert
    Pirotte, Bernard
    Diederich, Marc
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (11) : 4714 - 4733